Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132422) titled 'Application of Image-Guided Technology in the Interventional Diagnosis and Treatment of Breast Diseases' on Sept. 14.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Condition:
Suspicious breast lesions that are occult on conventional imaging and only visible on MRI
Intervention:
Gold Standard:Final pathology from MRI-guided biopsy served as the reference standard, with malignancies confirmed by surgical histopathology.For benign biopsy cases without surgery, MRI follow-up (>=6 months) wi...